AI assistant
Sun Pharmaceutical Industries Ltd. — Regulatory Filings 2024
Feb 1, 2024
59215_rns_2024-02-01_45e8a3ef-1d89-4068-935f-e798b272b9de.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: [email protected] CIN: L24230GJ1993PLC019050
==> picture [60 x 82] intentionally omitted <==
February 01, 2024
National Stock Exchange of India Limited Scrip Symbol: SUNPHARMA
BSE Limited Scrip Code: 524715
Sub: Intimation regarding issuance of duplicate share certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of duplicate share certificate issued in respect of the following shareholder:
shareholder: |
||||||
|---|---|---|---|---|---|---|
| Date of Issue | Folio No. |
Name of the Shareholder |
Share Certificate No. |
Share Distinctive Nos. |
No. of shares of Re.1 each |
|
| 01-02-2024 | 012411 | SNEHLATA SUBODH MOHTA |
44047 | 1027211641 | 1027211820 | 360 |
| 50681 | 1036024761 | 1036024940 |
For Sun Pharmaceutical Industries Limited
Anoop Digitally signed by Anoop Anjanikumar Anjanikumar Deshpande Date: 2024.02.01 18:43:11 Deshpande +05'30' (Anoop Deshpande)
Company Secretary and Compliance Officer ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives